Skip to main content

Advertisement

Log in

Neuroborreliosis (nervous system lyme disease)

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

Treatment of nervous system Lyme disease depends on the severity and site of involvement. Although some data indicate that uncomplicated Lyme meningitis can be treated effectively with oral doxycycline, central nervous system infection (meningitis, radiculitis, encephalomyelitis, and cranial neuritis) is usually treated with parenteral antibiotics for 14 to 30 days, depending on disease severity, as is severe and progressive peripheral nervous system involvement. Ceftriaxone, 2 g/d, is the most commonly used regimen; cefotaxime, 2 g every 8 hours, appears to be equally effective. Penicillin in meningeal doses is also effective, perhaps slightly less so than the third-generation cephalosporins, but it is less convenient to administer. For patients with prohibitive drug allergies, treatment with oral doxycycline in doses of 300 to 400 mg/d may be effective. In patients with facial palsy or with indolent peripheral neuropathies, a trial of oral medication (doxycycline, 100 mg two or three times a day, or amoxicillin, 500 to 1000 mg three times a day for 21 to 30 days) is reasonable. Patients for whom this fails are treated with parenteral medications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Pediatric Lyme Disease Study Group: Lyme disease in children in southeastern Connecticut. N Engl J Med 1996, 335:1270–1274.

    Article  Google Scholar 

  2. Luft BJ, Steinman CR, Neimark HC, et al.: Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection. JAMA 1992, 267:1364–1367.

    Article  PubMed  CAS  Google Scholar 

  3. Nichol G, Dennis DT, Steere AC, et al.: Test-treatment strategies for patients suspected of having Lyme. Ann Intern Med 1998, 128:37–48. Analysis of costs and benefits of testing for and treating Lyme disease in various settings.

    PubMed  CAS  Google Scholar 

  4. Reid MC, Schoen RT, Evans J, et al.: The consequences of overdiagnosis and overtreatment of Lyme disease. Ann Intern Med 1998, 128:354–362.

    PubMed  CAS  Google Scholar 

  5. Dattwyler RJ, Halperin JJ, Volkman DJ, Luft BJ: Treatment of late Lyme disease. Lancet 1988, 1:1191–1193.

    Article  PubMed  CAS  Google Scholar 

  6. Dattwyler RJ, Luft BJ, Maladorno D, et al.: Treatment of late Lyme disease—a comparison of 2 weeks vs 4 weeks of ceftriaxone [abstract]. Proceedings of the Seventh International Congress on Lyme Borreliosis. San Francisco: International Congress on Lyme Borreliosis; 1996:186. This abstract describes a large multicenter, randomized trial demonstrating the efficacy of 2-week therapy.

    Google Scholar 

  7. Pfister HW, Preac MV, Wilske B, Einhaupl KM: Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis: a prospective randomized study. Arch Neurol 1989, 46:1190–1194.

    PubMed  CAS  Google Scholar 

  8. Dattwyler RJ, Luft BJ, Kunkel MJ, et al.: Ceftriaxone compared with doxycycline for the treatment of acute Lyme disease. N Engl J Med 1997, 337:289–294.

    Article  PubMed  CAS  Google Scholar 

  9. Karlsson M, Hammers-Berggren S, Lindquist L, et al.: Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology 1994, 44:1203–1207. Demonstrates the efficacy of oral doxycycline in Lyme meningitis.

    PubMed  CAS  Google Scholar 

  10. Luger SW, Paparone P, Wormser GP, et al.: Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans. Antimicrob Agents Chemother 1995, 39:661–667.

    PubMed  CAS  Google Scholar 

  11. Luft BJ, Dattwyler RJ, Johnson RC, et al.: Azithromycin compared with amoxicillin in the treatment of erythema migrans. Ann Intern Med 1996, 124:785–791.

    PubMed  CAS  Google Scholar 

  12. Sigal LH, Zahradnik JM, Lavin P, et al.: A vaccine consisting of recombinant Borrelia burgdorferi outer-surface. N Engl J Med 1998, 339:216–222.

    Article  PubMed  CAS  Google Scholar 

  13. Steere AC, Sikand VK, Meurice F, et al.: Vaccination against Lyme disease with recombinant Borrelia burgdorferi. N Engl J Med 1998, 339:209–215.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Halperin, J.J. Neuroborreliosis (nervous system lyme disease). Curr Treat Options Neurol 1, 139–145 (1999). https://doi.org/10.1007/s11940-999-0013-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-999-0013-9

Keywords

Navigation